The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Clonazepam Rosemont 0.5 mg/5 ml oral solution



Taw Pharma (Ireland) LimitedPA23081/009/001

Main Information

Trade NameClonazepam Rosemont 0.5 mg/5 ml oral solution
Active SubstancesClonazepam
Dosage FormOral solution
Licence HolderTaw Pharma (Ireland) Limited
Licence NumberPA23081/009/001

Group Information

ATC CodeN03AE Benzodiazepine derivatives
N03AE01 clonazepam

Status

License statusAuthorised
Licence Issued24/02/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4 Part 1 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back